Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Peter R. Bär"'
Autor:
Peter R. Bär
Publikováno v:
European Journal of Pharmacology. 719:2-8
This text is based on three long interviews in Utrecht University′s Faculty Club, and on almost 40 years of working together in the same city, the same department, the same university.
Autor:
Peter R. Bär, W.H. Gispen, Eldon E. Geisert, S. Dijkstra, Alex J. Lankhorst, Frank P.T. Hamers, Elbert A.J. Joosten, Simone E.J. Duis, I.M. Pans, H. Veldman
Publikováno v:
Experimental Neurology. 202:57-66
We previously demonstrated that the tetraspanin protein CD81 is up-regulated by astrocytes and microglia after traumatic spinal cord injury in rats and that CD81 is involved in adhesion and proliferation of cultured astrocytes and microglia. Since th
Publikováno v:
Neuroscience Letters. 392:22-26
To investigate the sensitivity of human Schwann cells to cisplatin (cis-DDP), different approaches to estimate DNA damage were used: the comet assay, morphological evaluation of the granular condensation of nuclear chromatin and the terminal transfer
Publikováno v:
Neuroscience Research Communications. 35:96-104
Two cytoprotective agents, ethiofos (WR2721) and nerve growth factor (NGF), were used to diminish cisplatin-induced toxicity in Schwann cell cultures. The effect of both studied agents was estimated by a micronucleus test and the comet assay. The com
Autor:
Klaas Nicolay, Peter R. Bär, Jeannette Hofmeijer, L. J. Kappelle, Janneke Schepers, H. B. van der Worp, Wouter B. Veldhuis
Publikováno v:
Brain Research, 1013(1), 74-82. Elsevier
We aimed to establish a rat model of space-occupying hemispheric infarction to evaluate potential treatment strategies. For adequate timing of therapy in future experiments, we studied the development of tissue damage, edema formation, and perfusion
Autor:
Jeannette Hofmeijer, Wouter B. Veldhuis, Klaas Nicolay, H. B. van der Worp, Peter R. Bär, Janneke Schepers, L.J. Kappelle
Publikováno v:
Stroke : a Journal of Celebral Circulation, 35(6), 1476-1481. Lippincott Williams and Wilkins Ltd.
Background and Purpose— There is no conclusive experimental support that decompressive surgery in late stages of space-occupying cerebral infarction will improve outcome. We studied the effects of delayed decompressive surgery on the development of
Autor:
H. Veldman, J. de Leeuw van Weenen, Geert Jan Groeneveld, John H. J. Wokke, Jan H. Veldink, L.H. van den Berg, F.L. van Muiswinkel, Peter R. Bär
Publikováno v:
Neuroscience Letters. 352:175-178
Transgenic mice overexpressing the human mutated form (G93A) of Cu,Zn-superoxide dismutase (mSOD1) develop motor neuron degeneration resembling amyotrophic lateral sclerosis. In vitro studies have shown that mSOD1-induced, reactive oxygen species-med
Autor:
Peter R. Bär, Liselijn A. B. Wisman, Pierre N. E. De Graan, Freek L. Van Muiswinkel, Elly M. Hol
Publikováno v:
NeuroReport. 14:1967-1970
Amyotrophic lateral sclerosis is an incurable disease in which cerebral and spinal motoneurons degenerate, causing paralysis and death within 2-5 years. One of the pathogenic factors of motoneuron death is a chronic excess of glutamate, which exceeds
Autor:
Gerrit A. Veldink, Johannes F.G. Vliegenthart, Klaas Nicolay, Wouter B. Veldhuis, Peter R. Bär, Mauro Maccarrone, Vincenzo Di Marzo, Mario van der Stelt
Publikováno v:
Molecular Neurobiology, 26(2-3), 317-346. Humana Press
The endocannabinoid system is a valuable target for drug discovery, because it is involved in the regulation of many cellular and physiological functions. The endocannabinoid system constitutes the endogenous lipids anandamide, 2-arachidonoylglycerol
Publikováno v:
Brain Research. 922:243-249
Chronic treatment of rat cortical slices with a relative low concentration of mitochondrial inhibitor malonate leads to cortical motoneuron (CMN) death. In the neurodegenerative disease amyotrophic lateral sclerosis (ALS) corticospinal neurons, CMNs